Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory

Author:

Gluzman Mark1ORCID,Scott Jacob G.2ORCID,Vladimirsky Alexander3ORCID

Affiliation:

1. Center for Applied Mathematics, Cornell University, Ithaca, NY, USA

2. Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA

3. Department of Mathematics and Center for Applied Mathematics, Cornell University, 561 Malott Hall, Ithaca, NY 14853-4201, USA

Abstract

Recent clinical trials have shown that adaptive drug therapies can be more efficient than a standard cancer treatment based on a continuous use of maximum tolerated doses (MTD). The adaptive therapy paradigm is not based on a preset schedule; instead, the doses are administered based on the current state of tumour. But the adaptive treatment policies examined so far have been largely ad hoc. We propose a method for systematically optimizing adaptive policies based on an evolutionary game theory model of cancer dynamics. Given a set of treatment objectives, we use the framework of dynamic programming to find the optimal treatment strategies. In particular, we optimize the total drug usage and time to recovery by solving a Hamilton–Jacobi–Bellman equation. We compare MTD-based treatment strategy with optimal adaptive treatment policies and show that the latter can significantly decrease the total amount of drugs prescribed while also increasing the fraction of initial tumour states from which the recovery is possible. We conclude that the use of optimal control theory to improve adaptive policies is a promising concept in cancer treatment and should be integrated into clinical trial design.

Funder

NIH Case Comprehensive Cancer Center

Division of Mathematical Sciences

Calabresi Clinical Oncology Research Program, National Cancer Institute

Simons Foundation

Publisher

The Royal Society

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference55 articles.

1. Tumor heterogeneity: Causes and consequences

2. The Hallmarks of Cancer

3. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

4. Somatic clonal evolution: A selection-centric perspective

5. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;Browder T;Cancer Res.,2000

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3